Carotid Artery Disease Screening Should Make AHRQ Research List – Guidant
This article was originally published in The Gray Sheet
Executive Summary
Guidant is requesting the Agency for Healthcare Research & Quality to assign the study of female cardiovascular care quality to a list of CMS research priorities to be generated under the Medicare Modernization Act
You may also be interested in...
Bill Would Require Device Sponsors To Stratify PMA Trial Data By Gender
Cardiovascular device manufacturers would be required to stratify clinical trial information for PMA submissions by gender, race and ethnicity under the "HEART for Women Act" (S 2278)
Bill Would Require Device Sponsors To Stratify PMA Trial Data By Gender
Cardiovascular device manufacturers would be required to stratify clinical trial information for PMA submissions by gender, race and ethnicity under the "HEART for Women Act" (S 2278)
Testing women’s hearts
Women at risk for coronary artery disease are less likely to be referred to the appropriate diagnostic test than men, Jennifer Mieres, MD, North Shore University Hospital, Manhasset, N.Y., et al., write in the Feb. 1 issue of Circulation. Computed tomography, MRI and carotid intima-media thickness - "three relatively new and rapidly developing imaging technologies" - have not "amassed the wealth of evidence that would clearly define their role in the clinical evaluation of women with CAD," the authors write. In comments to the Agency for Healthcare Research & Quality, Guidant has urged additional research on women and heart disease (1"The Gray Sheet" May 24, 2004, p. 20)...